{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:51:49Z","timestamp":1793238709565,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Abnormal cancer antioxidant capacity is considered as a potential mechanism of tumor malignancy. Modulation of oxidative stress status is emerging as an anti-cancer treatment. Our previous studies have found that Nestin-knockdown cells were more sensitive to oxidative stress in non-small cell lung cancer (NSCLC). However, the molecular mechanism by which Nestin protects cells from oxidative damage remains unclear. Here, we identify a feedback loop between Nestin and Nrf2 maintaining the redox homeostasis. Mechanistically, the ESGE motif of Nestin interacts with the Kelch domain of Keap1 and competes with Nrf2 for Keap1 binding, leading to Nrf2 escaping from Keap1-mediated degradation, subsequently promoting antioxidant enzyme generation. Interestingly, we also map that the antioxidant response elements (AREs) in the Nestin promoter are responsible for its induction via Nrf2. Taken together, our results indicate that the\u00a0Nestin\u2013Keap1\u2013Nrf2 axis regulates cellular redox homeostasis and confers oxidative stress resistance in NSCLC.<\/jats:p>","DOI":"10.1038\/s41467-019-12925-9","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:03:23Z","timestamp":1573038203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Nestin regulates cellular redox homeostasis in lung cancer through the Keap1\u2013Nrf2 feedback loop"],"prefix":"10.1038","volume":"10","author":[{"given":"Jiancheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9672-7583","authenticated-orcid":false,"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Peng Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"12925_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrm3801","volume":"15","author":"KM Holmstrom","year":"2014","unstructured":"Holmstrom, K. M. & Finkel, T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 15, 411\u2013421 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"12925_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"M Murphy","year":"2009","unstructured":"Murphy, M. How mitochondria produce reactive oxygen species. Biochem. J. 417, 1\u201313 (2009).","journal-title":"Biochem. J."},{"key":"12925_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","volume":"10","author":"PT Schumacker","year":"2006","unstructured":"Schumacker, P. T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10, 175\u2013176 (2006).","journal-title":"Cancer Cell"},{"key":"12925_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham, D., Alexandre, J. & Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug Discov. 8, 579\u2013591 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"12925_CR5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1089\/ars.2010.3301","volume":"13","author":"DD Zhang","year":"2010","unstructured":"Zhang, D. D. The Nrf2-Keap1-ARE signaling pathway: the regulation and dual function of Nrf2 in cancer. Antiredox. Redox Signal.\n                           13, 1623\u20131626 (2010).","journal-title":"Antiredox. Redox Signal."},{"key":"12925_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1124\/pr.110.004333","volume":"64","author":"Q Ma","year":"2012","unstructured":"Ma, Q. & He, X. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol. Rev. 64, 1055\u20131081 (2012).","journal-title":"Pharmacol. Rev."},{"key":"12925_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63, 173\u2013184 (2016).","journal-title":"Hepatology"},{"key":"12925_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ccell.2016.04.006","volume":"29","author":"A Umemura","year":"2016","unstructured":"Umemura, A. et al. p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells. Cancer Cell 29, 935\u2013948 (2016).","journal-title":"Cancer Cell"},{"key":"12925_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34","author":"T Suzuki","year":"2013","unstructured":"Suzuki, T., Motohashi, H. & Yamamoto, M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 34, 340\u2013346 (2013).","journal-title":"Trends Pharmacol. Sci."},{"key":"12925_CR10","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","volume":"24","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi, A. et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130\u20137139 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"12925_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H Sies","year":"2017","unstructured":"Sies, H., Berndt, C. & Jones, D. P. Oxidative stress. Annu. Rev. Biochem. 86, 715\u2013748 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"12925_CR12","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","volume":"23","author":"DD Zhang","year":"2003","unstructured":"Zhang, D. D. & Hannink, M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23, 8137\u20138151 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"12925_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ccell.2017.10.009","volume":"32","author":"JD Hayes","year":"2017","unstructured":"Hayes, J. D. & Dinkova-Kostova, A. T. Oncogene-stimulated congestion at the KEAP1 stress signaling Hub allows bypass of NRF2 and induction of NRF2-target genes that promote tumor survival. Cancer Cell 32, 539\u2013541 (2017).","journal-title":"Cancer Cell"},{"key":"12925_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccell.2017.09.008","volume":"32","author":"W Ge","year":"2017","unstructured":"Ge, W. et al. iASPP is an antioxidative factor and drives cancer growth and drug resistance by competing with Nrf2 for Keap1 binding. Cancer Cell 32, 561\u2013573.e566 (2017).","journal-title":"Cancer Cell"},{"key":"12925_CR15","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-12-4400","volume":"73","author":"BE Hast","year":"2013","unstructured":"Hast, B. E. et al. Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. Cancer Res. 73, 2199\u20132210 (2013).","journal-title":"Cancer Res."},{"key":"12925_CR16","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-16-2204","volume":"77","author":"K Lu","year":"2017","unstructured":"Lu, K. et al. NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction. Cancer Res. 77, 2881\u20132892 (2017).","journal-title":"Cancer Res."},{"key":"12925_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nature16142","volume":"528","author":"A Orthwein","year":"2015","unstructured":"Orthwein, A. et al. A mechanism for the suppression of homologous recombination in G1 cells. Nature 528, 422\u2013426 (2015).","journal-title":"Nature"},{"key":"12925_CR18","doi-asserted-by":"publisher","first-page":"23719","DOI":"10.1074\/jbc.M116.729418","volume":"291","author":"KM Mulvaney","year":"2016","unstructured":"Mulvaney, K. M. et al. Identification and characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) substrate. J. Biol. Chem. 291, 23719\u201323733 (2016).","journal-title":"J. Biol. Chem."},{"key":"12925_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tcb.2009.11.004","volume":"20","author":"DM Toivola","year":"2010","unstructured":"Toivola, D. M., Strnad, P., Habtezion, A. & Omary, M. B. Intermediate filaments take the heat as stress proteins. Trends Cell Biol. 20, 79\u201391 (2010).","journal-title":"Trends Cell Biol."},{"key":"12925_CR20","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1038\/sj.emboj.7601366","volume":"25","author":"CM Sahlgren","year":"2006","unstructured":"Sahlgren, C. M. et al. A nestin scaffold links Cdk5\/p35 signaling to oxidant\u2010induced cell death. EMBO J. 25, 4808\u20134819 (2006).","journal-title":"EMBO J."},{"key":"12925_CR21","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1038\/onc.2015.370","volume":"35","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Nestin regulates proliferation and invasion of gastrointestinal stromal tumor cells by altering mitochondrial dynamics. Oncogene 35, 3139\u20133150 (2016).","journal-title":"Oncogene"},{"key":"12925_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.chembiol.2010.03.013","volume":"17","author":"W Hur","year":"2010","unstructured":"Hur, W. et al. A small-molecule inducer of the antioxidant response element. Chem. Biol. 17, 537\u2013547 (2010).","journal-title":"Chem. Biol."},{"key":"12925_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1128\/MCB.25.1.162-171.2005","volume":"25","author":"M Furukawa","year":"2005","unstructured":"Furukawa, M. & Xiong, Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol. 25, 162\u2013171 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"12925_CR24","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","volume":"24","author":"DD Zhang","year":"2004","unstructured":"Zhang, D. D., Lo, S. C., Cross, J. V., Templeton, D. J. & Hannink, M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24, 10941\u201310953 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"12925_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","volume":"18","author":"L Neckers","year":"2012","unstructured":"Neckers, L. & Workman, P. Hsp90 molecular chaperone inhibitors: are we there yet? Clin. Cancer Res. 18, 64\u201376 (2012).","journal-title":"Clin. Cancer Res."},{"key":"12925_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829\u2013834 (2010).","journal-title":"Nature"},{"key":"12925_CR27","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/cr.2014.149","volume":"24","author":"MH Jiang","year":"2014","unstructured":"Jiang, M. H. et al. Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction. Cell Res. 24, 1466\u20131485 (2014).","journal-title":"Cell Res."},{"key":"12925_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biomaterials.2015.01.029","volume":"50","author":"MH Jiang","year":"2015","unstructured":"Jiang, M. H. et al. Nestin(+) kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury. Biomaterials 50, 56\u201366 (2015).","journal-title":"Biomaterials"},{"key":"12925_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1083\/jcb.131.2.453","volume":"131","author":"J Frisen","year":"1995","unstructured":"Frisen, J., Johansson, C. B., Torok, C., Risling, M. & Lendahl, U. Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J. Cell Biol. 131, 453\u2013464 (1995).","journal-title":"J. Cell Biol."},{"key":"12925_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13402-014-0193-5","volume":"37","author":"EC Tampaki","year":"2014","unstructured":"Tampaki, E. C. et al. Nestin involvement in tissue injury and cancer\u2014a potential tumor marker? Cell Oncol. 37, 305\u2013315 (2014).","journal-title":"Cell Oncol."},{"key":"12925_CR31","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/nn.3553","volume":"16","author":"P Li","year":"2013","unstructured":"Li, P. et al. A population of Nestin-expressing progenitors in the cerebellum exhibits increased tumorigenicity. Nat. Neurosci. 16, 1737\u20131744 (2013).","journal-title":"Nat. Neurosci."},{"key":"12925_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cell.2014.05.051","volume":"158","author":"DF Tschaharganeh","year":"2014","unstructured":"Tschaharganeh, D. F. et al. p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. Cell 158, 579\u2013592 (2014).","journal-title":"Cell"},{"key":"12925_CR33","doi-asserted-by":"crossref","unstructured":"Li, P. et al. Nestin mediates hedgehog pathway tumorigenesis. Cancer Res. 76, 5573\u20135583 (2016).","DOI":"10.1158\/0008-5472.CAN-16-1547"},{"key":"12925_CR34","doi-asserted-by":"publisher","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","volume":"285","author":"A Jain","year":"2010","unstructured":"Jain, A. et al. p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 285, 22576\u201322591 (2010).","journal-title":"J. Biol. Chem."},{"key":"12925_CR35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1084\/jem.20151208","volume":"213","author":"C Yang","year":"2016","unstructured":"Yang, C. et al. Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma. J. Exp. Med. 213, 859\u2013875 (2016).","journal-title":"J. Exp. Med."},{"key":"12925_CR36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.molcel.2009.04.029","volume":"34","author":"W Chen","year":"2009","unstructured":"Chen, W. et al. Direct interaction between Nrf2 and p21(Cip1\/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol. Cell 34, 663\u2013673 (2009).","journal-title":"Mol. Cell"},{"key":"12925_CR37","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1038\/onc.2017.161","volume":"36","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells. Oncogene 36, 5321\u20135330 (2017).","journal-title":"Oncogene"},{"key":"12925_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcel.2013.04.022","volume":"51","author":"NF Villeneuve","year":"2013","unstructured":"Villeneuve, N. F. et al. USP15 negatively regulates Nrf2 through deubiquitination of Keap1. Mol. Cell 51, 68\u201379 (2013).","journal-title":"Mol. Cell"},{"key":"12925_CR39","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","volume":"26","author":"KI Tong","year":"2006","unstructured":"Tong, K. I. et al. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell. Biol. 26, 2887\u20132900 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"12925_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","volume":"26","author":"A Kobayashi","year":"2006","unstructured":"Kobayashi, A. et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 26, 221\u2013229 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"12925_CR41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molcel.2006.01.013","volume":"21","author":"B Padmanabhan","year":"2006","unstructured":"Padmanabhan, B. et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21, 689\u2013700 (2006).","journal-title":"Mol. Cell"},{"key":"12925_CR42","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1371\/journal.pmed.0030420","volume":"3","author":"A Singh","year":"2006","unstructured":"Singh, A. et al. Dysfunctional KEAP1\u2013NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3, e420 (2006).","journal-title":"PLoS Med."},{"key":"12925_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1124\/pr.117.014753","volume":"70","author":"A Caudrado","year":"2018","unstructured":"Caudrado, A. et al. Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach. Pharmacol. Rev. 70, 348\u2013383 (2018).","journal-title":"Pharmacol. Rev."},{"key":"12925_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","volume":"85","author":"HK Bryan","year":"2013","unstructured":"Bryan, H. K., Olayanju, A., Goldring, C. E. & Park, B. K. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem. Pharmacol. 85, 705\u2013717 (2013).","journal-title":"Biochem. Pharmacol."},{"key":"12925_CR45","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/cdd.2015.49","volume":"22","author":"D Jimenez-Blasco","year":"2015","unstructured":"Jimenez-Blasco, D., Santofimia-Casta\u00f1o, P., Gonzalez, A., Almeida, A. & Bola\u00f1os, J. P. Astrocyte NMDA receptors\u2019 activity sustains neuronal survival through a Cdk5-Nrf2 pathway. Cell Death Differ. 22, 1877\u20131889 (2015).","journal-title":"Cell Death Differ."},{"key":"12925_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05808-y","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Nuclear Nestin deficiency drives tumor senescence via lamin A\/C-dependent nuclear deformation. Nat. Commun. 9, 3613 (2018).","journal-title":"Nat. Commun."},{"key":"12925_CR47","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ajpath.2016.01.020","volume":"186","author":"CB Gomes","year":"2016","unstructured":"Gomes, C. B. et al. TET2 Negatively regulates nestin expression in human melanoma. Am. J. Pathol. 186, 1427\u20131434 (2016).","journal-title":"Am. J. Pathol."},{"key":"12925_CR48","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.molcel.2014.01.033","volume":"53","author":"SN Zucker","year":"2014","unstructured":"Zucker, S. N. et al. Nrf2 amplifies oxidative stress via induction of Klf9. Mol. Cell 53, 916\u2013928 (2014).","journal-title":"Mol. Cell"},{"key":"12925_CR49","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2014.77","volume":"134","author":"PJ Dziunycz","year":"2014","unstructured":"Dziunycz, P. J. et al. The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A. J. Invest. Dermatol. 134, 1998\u20132004 (2014).","journal-title":"J. Invest. Dermatol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12925-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12925-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12925-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T01:51:55Z","timestamp":1671241915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12925-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["12925"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-12925-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5043"}}